Showing results (101-110 of 261) with videos related to
Sort By:
Pageof 27
Allergology International : Official Journal of the Japanese Society of Allergology|December 26, 2013
Characteristics of the Chiba environmental challenge chamberSawako Hamasaki, Yoshitaka Okamoto, Syuji Yonekura, et al.JTO Clinical and Research Reports|May 2, 2022
Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients With ALK-rearranged NSCLC Previously Treated With AlectinibYuki Takeyasu, Tatsuya Yoshida, Ken Masuda, et al.Future Oncology (London, England)|August 14, 2023
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study)Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya, et al.Nucleic Acids Symposium Series (2004)|September 15, 2009
Characterization of RNA aptamers against SRP19 protein having sequences different from SRP RNAYuki Haraguchi, Kanako Kuwasako, Yutaka Muto, et al.Journal of Thoracic Disease|August 3, 2019
Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitorsYasuhiro Kato, Yukio Hosomi, Kageaki Watanabe, et al.Anticancer Research|January 29, 2018
Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung CancerYasuhiro Kato, Jumpei Kashima, Kageaki Watanabe, et al.Respiratory Investigation|July 4, 2024
The remarkable antitumor efficacy of corticosteroid treatment in patients with refractory thymomasTomohiro Tanaka, Yasushi Goto, Ken Masuda, et al.Journal of Bacteriology|July 10, 2007
Structural characterization of the ribosome maturation protein, RimMSakura Suzuki, Ayako Tatsuguchi, Eiko Matsumoto, et al.Oncotargets and Therapy|September 8, 2016
Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1Yoshiro Nakahara, Yusuke Takagi, Yukio Hosomi, et al.Respiratory Investigation|January 1, 2022
Correlation between body mass index and efficacy of anti-PD-1 inhibitor in patients with non-small cell lung cancerAkiko Tateishi, Hidehito Horinouchi, Tatsuya Yoshida, et al.Pageof 27